Welcome to MasterGenix, developers of T-Cl@ss:
online tumor diagnosis

We have developed our first product TCLASS® a proprietary, very powerful molecular multi-class tumor classifier which makes it possible to dissect cancers in silico with over 90% accuracy and allow for the determination of tumor subtype, metastatic tumor origin and a large number of tumor characteristics using data obtained from a single gene expression microarray.

In particular, this tool is very powerful for diagnosing cancers of unknown primary origin and bring better treatment opportunities for these patients with an extreme bleak prognosis and for whom little accurate diagnostic tools are currently available .

TCLASS® will be initially offered as an online diagnostic service based on gene expression analysis using the extremely reproducible and robust Affymetrix GeneChip Human Genome U133 Plus 2.0 Array platform. The clinicians can analyze online their Cel files, produced by their own (local) microarray core facility of CLIA laboratory